COVID-19 and cancer: start the resolution!

COVID-19 and cancer: start the resolution!

Coronavirus disease 2019 (COVID-19) due to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been an ongoing pandemic causing significant morbidity and mortality worldwide. The “cytokine storm” is a critical driving force in severe COVID-19 cases, leading to hyperinflam...

Full description

Bibliographic Details
Main Authors: Barksdale, C. (Author), Kipper, F.C (Author), Panigrahy, D. (Author), Serhan, C.N (Author), Subbian, S. (Author), Tripathy, S. (Author)
Format: Article
Language:English
Published: Springer 2022
Subjects:
antiinflammatory activity
antithrombotic activity
antiviral activity
antiviral therapy
autacoid
cancer control
cancer therapy
controlled study
coronavirus disease 2019
COVID-19
cytokine
cytokine production
cytokine release syndrome
Cytokine Release Syndrome
cytokine storm
Cytokine storm
endogenous variable
enzyme synthesis
human
human cell
Humans
hyperinflammation
icosanoid
immunopathology
infection control
inflammation
Inflammation
malignant neoplasm
neoplasm
Neoplasms
nonhuman
Note
pandemic
Pandemics
Resolution of inflammation
SARS-CoV-2
specialized pro resolving mediator
transcription factor
unclassified drug
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items